.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Practice

Dexpramipexole Lowers Blood and Tissue Eosinophils Without Severe Adverse Reactions

March 14th 2017

By The Center for Biosimilars Staff

Article

FDA's Director of Drug Evaluation Urges Congress to Pass the BsUFA Reauthorization

March 4th 2017

By Jackie Syrop

Article

US and EU Agree on Mutual Recognition of Drug Manufacturing Inspections

March 3rd 2017

By Jackie Syrop

Article

Targeted Regenerative Meds Hold Promise for RA Patients Resistant to anti-TNF Agents

March 1st 2017

By Jackie Syrop

Article

Diabetes Drugs Could Be Next Frontier of Biosimilar Development

March 1st 2017

By Christina Mattina

Article

Will US Follow UK on Managed Biosimilar Switching of IBD Patients on Infliximab?

February 22nd 2017

By Jackie Syrop

Article

Herceptin, Rituxan Biosimilars Might Soon Reach Oncologists in Europe

February 16th 2017

By Jackie Syrop

Article